Neonatal phototherapy: how can we explain the apparent lack of consensus in phototherapy practices between institutions?

Based on your experience, how do you explain the apparent lack of consensus in phototherapy practices between institutions?

There is no lack of consensus regarding phototherapy practices in term newborns. On the contrary, there is a well-established consensus, based on the recommendations of the American Academy of Pediatrics, which are regularly updated, with a version published in 2005 and the most recent in 2023.

In contrast, there is no strict consensus regarding phototherapy in preterm infants, especially in infants born before 34 weeks’ gestation, including very preterm infants.
This is a complex situation and can be explained in part by the fact that phototherapy has been used for almost 70 years, but there are only two randomized trials in the entire history of phototherapy in preterm infants, with relatively contradictory results.

In addition, there are no actual long-term follow-up studies to accurately define the levels of bilirubin that are dangerous or of concern in these children.
These studies are extremely difficult, if not impossible, to conduct, which explains the existence of a large grey area of uncertainty in the care of premature babies and, consequently, a heterogeneity of practices between establishments.

Important note : The information and opinions expressed by Professor Daniele De Luca are intended to enlighten practice. They are not a substitute for local protocols or the clinical judgment of the care teams.